Integrated Molecular and Cellular Immunology Core
Integrated Molecular and Cellular Immunology Core
批准号:
8705988
负责人:
Leslie S Kean
金额:
$22.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2017-07-31
关键词:
AddressAutopsyB-LymphocytesBiological AssayBiopsyCell SeparationCell physiologyCellular ImmunologyChronicClinicCollaborationsComplexComputer softwareDNAData SetDevelopmentElementsEnd stage renal failureEnsureFaceFlow CytometryHistopathologyHomologous GeneHuman Herpesvirus 4Immune ToleranceImmune responseImmunityImmunogeneticsImmunologic MarkersImmunologic MonitoringImmunosuppressionInformation ManagementInstructionInterventionKidneyKidney TransplantationLatent VirusMacaca mulattaMethodologyMolecularMolecular AnalysisMolecular ImmunologyMolecular VirologyMonitorOrganOutcomePatientsPolyomavirusProceduresPublishingRNARegimenReproducibilityResearchResearch PersonnelRiskSafetySamplingServicesSimian virus 40SystemT-LymphocyteTechnologyToxic effectTranslatingTransplant RecipientsTransplantationTransplantation ToleranceViralbasebiobankclinically relevantdata managementdesignimprovedmembernonhuman primatenovelresearch studytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
The Molecular and Cellular Immunology Core:
The Emory Transplant Center and this Consortium benefits from an integrated approach to performing nonhuman primate (NHP) transplant tolerance research. The hub of this integration is the integrated Molecular and Cellular Immunology Core (MClC), which coordinates and streamlines all common assays and procedures, as well as the NHP procurement and typing needs for all members of the ETC. The MClC is comprised of five interacting elements: (1) The MHC Immunogenetics and Typing Core. (2) The Flow Cytometry Core. (3) The NHP Histopathology Core. (4) The Molecular Immunology and Virology Core and (5) The Functional Protective Immunity Core. Each Core addresses a critical need for the conduct of the complex experiments that are proposed in each of the projects and promotes collaboration between investigators. As such, the development of these integrated services has significantly increased the efficiency and the rigor with which our group is able to execute complex NHP transplantation tolerance research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Immunology Core
-
批准号:10622125
-
项目类别:
-
资助金额:$54.76万
-
财政年份:2023
-
负责人:Leslie S Kean
-
依托单位:
Project 2: The New Era of Cellular Therapies For Lung Transplant Tolerance
-
批准号:10622128
-
项目类别:
-
资助金额:$106.68万
-
财政年份:2023
-
负责人:Leslie S Kean
-
依托单位:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
-
批准号:10698167
-
项目类别:
-
资助金额:$46.63万
-
财政年份:2022
-
负责人:Leslie S Kean
-
依托单位:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
-
批准号:10493799
-
项目类别:
-
资助金额:$47.88万
-
财政年份:2022
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10270361
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10457401
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10673079
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10474806
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10683141
-
项目类别:
-
资助金额:$98.93万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10474994
-
项目类别:
-
资助金额:$99.52万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:9301086
-
项目类别:
-
资助金额:$55.58万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:8841635
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:8930057
-
项目类别:
-
资助金额:$26.02万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:9329366
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8654260
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8821466
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8849765
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8569114
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
-
批准号:9358731
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2010
-
负责人:Leslie S Kean
-
依托单位:
Novel Biologic Therapies for GVHD
-
批准号:10664835
-
项目类别:
-
资助金额:$116.93万
-
财政年份:2010
-
负责人:Leslie S Kean
-
依托单位:
海外基金